Literature DB >> 17364232

Host innate immune response to Mycobacterium tuberculosis.

Kamlesh Bhatt1, Padmini Salgame.   

Abstract

This review focuses on recent progress in our understanding of Mycobacterium tuberculosis survival in macrophages, the interaction of M. tuberculosis with Toll-like receptors (TLRs) and the establishment of the link between innate and adaptive immunity, and TLRs and interferon-gamma-mediated antimicrobial pathways in macrophages. We also propose a paradigm that TLR2 signaling regulates the magnitude of the host Th1 response leading to either M. tuberculosis persistence and latent infection or replication and disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364232     DOI: 10.1007/s10875-007-9084-0

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.542


  164 in total

Review 1.  New insights into the function of granulomas in human tuberculosis.

Authors:  Timo Ulrichs; Stefan H E Kaufmann
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

2.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.

Authors:  P A Selwyn; D Hartel; V A Lewis; E E Schoenbaum; S H Vermund; R S Klein; A T Walker; G H Friedland
Journal:  N Engl J Med       Date:  1989-03-02       Impact factor: 91.245

3.  Different Toll-like receptor agonists induce distinct macrophage responses.

Authors:  B W Jones; T K Means; K A Heldwein; M A Keen; P J Hill; J T Belisle; M J Fenton
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

4.  Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7.

Authors:  L E Via; D Deretic; R J Ulmer; N S Hibler; L A Huber; V Deretic
Journal:  J Biol Chem       Date:  1997-05-16       Impact factor: 5.157

5.  IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection.

Authors:  Euan Lockhart; Angela M Green; JoAnne L Flynn
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

6.  Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression.

Authors:  Holly M Scott; JoAnne L Flynn
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

7.  Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis.

Authors:  A P Badewa; L J Quinton; J E Shellito; C M Mason
Journal:  Tuberculosis (Edinb)       Date:  2005-05       Impact factor: 3.131

8.  The chemokine receptor CXCR3 attenuates the control of chronic Mycobacterium tuberculosis infection in BALB/c mice.

Authors:  Soumya D Chakravarty; Jiayong Xu; Bao Lu; Craig Gerard; Joanne Flynn; John Chan
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

9.  Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol.

Authors:  M Denis
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

10.  T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons.

Authors:  J Estaquier; T Idziorek; W Zou; D Emilie; C M Farber; J M Bourez; J C Ameisen
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  86 in total

1.  Zebrafishing for tuberculosis infection.

Authors:  Liwei Wang
Journal:  Protein Cell       Date:  2010-04       Impact factor: 14.870

2.  Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.

Authors:  Christina L Lancioni; Qing Li; Jeremy J Thomas; XueDong Ding; Bonnie Thiel; Michael G Drage; Nicole D Pecora; Assem G Ziady; Samuel Shank; Clifford V Harding; W Henry Boom; Roxana E Rojas
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Tuberculosis: Autophagy is not the answer.

Authors:  Samuel M Behar; Eric H Baehrecke
Journal:  Nature       Date:  2015-12-09       Impact factor: 49.962

Review 4.  New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.

Authors:  Majid Faridgohar; Hassan Nikoueinejad
Journal:  Pathog Glob Health       Date:  2017-07-17       Impact factor: 2.894

5.  Mycobacterium tuberculosis antigen Wag31 induces expression of C-chemokine XCL2 in macrophages.

Authors:  Wei Cao; Shuai Tang; Hanying Yuan; Honghai Wang; Xin Zhao; Hong Lu
Journal:  Curr Microbiol       Date:  2008-07-11       Impact factor: 2.188

6.  Mycobacterium tuberculosis impairs dendritic cell functions through the serine hydrolase Hip1.

Authors:  Ranjna Madan-Lala; Jonathan Kevin Sia; Rebecca King; Toidi Adekambi; Leticia Monin; Shabaana A Khader; Bali Pulendran; Jyothi Rengarajan
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

7.  Influence of the tissue microenvironment on Toll-like receptor expression by CD11c+ antigen-presenting cells isolated from mucosal tissues.

Authors:  Shunsuke Takenaka; Sarah McCormick; Ekaterina Safroneeva; Zhou Xing; Jack Gauldie
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

Review 8.  Unraveling the Role of MicroRNAs in Mycobacterium tuberculosis Infection and Disease: Advances and Pitfalls.

Authors:  Cinthya Ruiz-Tagle; Rodrigo Naves; María Elvira Balcells
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

9.  Lower levels of interleukin-12 precede the development of tuberculosis among HIV-infected women.

Authors:  José Bordón; Michael W Plankey; Mary Young; Ruth M Greenblatt; Maria C Villacres; Audrey L French; Jie Zhang; Guy Brock; Savitri Appana; Betsy Herold; Helen Durkin; Jonathan E Golub; Rafael Fernandez-Botran
Journal:  Cytokine       Date:  2011-08-30       Impact factor: 3.861

10.  Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils.

Authors:  Heike L Rittner; Dagmar Hackel; Philipp Voigt; Shaaban Mousa; Andrea Stolz; Dominika Labuz; Michael Schäfer; Michael Schaefer; Christoph Stein; Alexander Brack
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.